Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBUS MEDICAL INCGMED · Entity 3496 | EVP, GC, Corporate Secretary | February 25, 2026 | February 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBUS MEDICAL INC
Report date February 25, 2026 · Filed February 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2026-02-25 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-25 · Exercise / conversion · Acquired 20,000 · Balance 20,000 Row 2 · 2026-02-25 · Sale · Disposed 20,000 · Balance 0 F1: This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated November 12, 2025 executed by the reporting person. |
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $43.58 · Expires 2029-01-22 | Direct | 20,000 |
Reported balance
After 2026-02-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-25 · Exercise / conversion · Disposed 20,000 · Balance 20,000 F2: These options were granted on January 22, 2019 and are fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated November 12, 2025 executed by the reporting person.
F2: These options were granted on January 22, 2019 and are fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2026 Filed Feb 27, 2026 22:53 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 20,000 | $0.00 Strike: $43.58 | $0.00 |
DisclosureSEC source: 0001193125-26-083348 · ownership.xml · derivative · entry 3 Huller Kelly · CIK 0001768417 · EVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,000 Underlying: Class A Common Stock · 20,000 shares Expires 2029-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on January 22, 2019 and are fully vested. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 22:53 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 20,000 | $94.50 | $1,890,000.00 |
DisclosureSEC source: 0001193125-26-083348 · ownership.xml · nonDerivative · entry 2 Huller Kelly · CIK 0001768417 · EVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated November 12, 2025 executed by the reporting person. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 22:53 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 20,000 | $43.58 | $871,600.00 |
DisclosureSEC source: 0001193125-26-083348 · ownership.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · EVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 22:22 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 10,000 | $0.00 Strike: $45.64 | $0.00 |
DisclosureSEC source: 0001193125-26-055137 · ownership.xml · derivative · entry 3 Huller Kelly · CIK 0001768417 · EVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 10,000 shares Expires 2028-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on February 2, 2018 and are fully vested. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 22:22 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 10,000 | $87.67 | $876,700.00 |
DisclosureSEC source: 0001193125-26-055137 · ownership.xml · nonDerivative · entry 2 Huller Kelly · CIK 0001768417 · EVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated November 12, 2025 executed by the reporting person. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 22:22 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 10,000 | $45.64 | $456,400.00 |
DisclosureSEC source: 0001193125-26-055137 · ownership.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · EVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 21:41 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 40,000 | $0.00 Strike: $94.15 | $0.00 |
DisclosureSEC source: 0001193125-26-021163 · ownership.xml · derivative · entry 1 Huller Kelly · CIK 0001768417 · EVP, GC, Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2036-01-21 F1 · derivative.exercise_date: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter. Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 22:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 7,500 | $0.00 Strike: $25.96 | $0.00 |
DisclosureSEC source: 0001193125-25-302649 · ownership.xml · derivative · entry 3 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 7,500 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on February 2, 2017 and are fully vested. Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 22:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 7,500 | $90.00 | $675,000.00 |
DisclosureSEC source: 0001193125-25-302649 · ownership.xml · nonDerivative · entry 2 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated December 4, 2024 executed by the reporting person. Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 22:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 7,500 | $25.96 | $194,700.00 |
DisclosureSEC source: 0001193125-25-302649 · ownership.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2025 Filed Mar 28, 2025 23:11 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 40,000 | $0.00 Strike: $92.42 | $0.00 |
DisclosureSEC source: 0000950170-25-047048 · ownership.xml · derivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2035-01-23 F1 · derivative.exercise_date: These options were granted on January 23, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:12 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 2,500 | $0.00 Strike: $24.21 | $0.00 |
DisclosureSEC source: 0000950170-24-133260 · ownership.xml · derivative · entry 3 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,500 shares Expires 2026-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on February 2, 2016 and are fully vested. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:12 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 2,500 | $87.00 | $217,501.50 |
DisclosureSEC source: 0000950170-24-133260 · ownership.xml · nonDerivative · entry 2 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated June 13, 2024 executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.00 to $87.075, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:12 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 2,500 | $24.21 | $60,525.00 |
DisclosureSEC source: 0000950170-24-133260 · ownership.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:21 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 5,000 | $0.00 Strike: $24.21 | $0.00 |
DisclosureSEC source: 0000950170-24-124127 · ownership.xml · derivative · entry 4 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,500 Underlying: Class A Common Stock · 5,000 shares Expires 2026-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on February 2, 2016 and are fully vested. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:21 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 2,500 | $82.00 | $205,000.00 |
DisclosureSEC source: 0000950170-24-124127 · ownership.xml · nonDerivative · entry 3 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated June 13, 2024 executed by the reporting person. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:21 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 2,500 | $80.02 | $200,050.00 |
DisclosureSEC source: 0000950170-24-124127 · ownership.xml · nonDerivative · entry 2 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,500 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated June 13, 2024 executed by the reporting person. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:21 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 5,000 | $24.21 | $121,050.00 |
DisclosureSEC source: 0000950170-24-124127 · ownership.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:39 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 7,500 | $0.00 Strike: $25.80 | $0.00 |
DisclosureSEC source: 0000950170-24-115648 · ownership.xml · derivative · entry 3 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 7,500 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on April 1, 2015 and are fully vested. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:39 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 7,500 | $75.02 | $562,649.25 |
DisclosureSEC source: 0000950170-24-115648 · ownership.xml · nonDerivative · entry 2 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: Not disclosed F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated June 13, 2024 executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $75.01 - $75.02, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:39 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 7,500 | $25.80 | $193,500.00 |
DisclosureSEC source: 0000950170-24-115648 · ownership.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 7,500 | $0.00 Strike: $24.90 | $0.00 |
DisclosureSEC source: 0000950170-24-026234 · ownership.xml · derivative · entry 4 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 7,500 shares Expires 2024-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on March 4, 2014 and are fully vested. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 3,115 | $54.53 | $169,860.95 |
DisclosureSEC source: 0000950170-24-026234 · ownership.xml · nonDerivative · entry 3 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated September 7, 2023 executed by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $54.43 - $54.64, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (3) to this Form 4. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 4,385 | $53.79 | $235,869.15 |
DisclosureSEC source: 0000950170-24-026234 · ownership.xml · nonDerivative · entry 2 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,115 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated September 7, 2023 executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $53.36 - $54.31, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 7,500 | $24.90 | $186,750.00 |
DisclosureSEC source: 0000950170-24-026234 · ownership.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:43 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 40,000 | $0.00 Strike: $53.75 | $0.00 |
DisclosureSEC source: 0000950170-24-008897 · ownership.xml · derivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2034-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| October 10, 2023 Filed Oct 19, 2023 21:04 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 5,000 | $0.00 Strike: $53.02 | $0.00 |
DisclosureSEC source: 0001209191-23-053188 · doc4.xml · derivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Class A Common Stock · 5,000 shares Expires 2033-09-01 F1 · derivative.exercise_date: These options were granted on October 10, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on September 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 26, 2023 Filed Feb 27, 2023 21:53 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 30,000 | $0.00 Strike: $75.18 | $0.00 |
DisclosureSEC source: 0001209191-23-013221 · doc4.xml · derivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Class A Common Stock · 30,000 shares Expires 2033-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:20 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 7,500 | $0.00 Strike: $12.59 | $0.00 |
DisclosureSEC source: 0001209191-22-059764 · doc4.xml · derivative · entry 3 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 7,500 shares Expires 2023-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on January 30, 2013 and are fully vested. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:20 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 7,500 | $75.00 | $562,500.75 |
DisclosureSEC source: 0001209191-22-059764 · doc4.xml · nonDerivative · entry 2 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.01, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:20 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 7,500 | $12.59 | $94,425.00 |
DisclosureSEC source: 0001209191-22-059764 · doc4.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 21:06 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 2,500 | $0.00 Strike: $15.34 | $0.00 |
DisclosureSEC source: 0001209191-22-024001 · doc4.xml · derivative · entry 3 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,500 shares Expires 2022-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on August 29, 2012 and are fully vested. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 21:06 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 2,500 | $75.59 | $188,962.50 |
DisclosureSEC source: 0001209191-22-024001 · doc4.xml · nonDerivative · entry 2 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.27 to $75.76, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 21:06 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 2,500 | $15.34 | $38,350.00 |
DisclosureSEC source: 0001209191-22-024001 · doc4.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 21:48 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 30,000 | $0.00 Strike: $63.68 | $0.00 |
DisclosureSEC source: 0001209191-22-005593 · doc4.xml · derivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Class A Common Stock · 30,000 shares Expires 2032-01-27 F1 · derivative.exercise_date: These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 21:50 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 30,000 | $0.00 Strike: $65.05 | $0.00 |
DisclosureSEC source: 0001209191-21-004037 · doc4.xml · derivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Class A Common Stock · 30,000 shares Expires 2031-01-14 F1 · derivative.exercise_date: These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 22:49 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 2,000 | $0.00 Strike: $11.28 | $0.00 |
DisclosureSEC source: 0001209191-20-065394 · doc4.xml · derivative · entry 3 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,000 shares Expires 2021-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on February 11, 2011 and are fully vested. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 22:49 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 2,000 | $66.15 | $132,300.00 |
DisclosureSEC source: 0001209191-20-065394 · doc4.xml · nonDerivative · entry 2 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 22:49 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 2,000 | $11.28 | $22,560.00 |
DisclosureSEC source: 0001209191-20-065394 · doc4.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:30 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 12,000 | $0.00 Strike: $11.28 | $0.00 |
DisclosureSEC source: 0001209191-20-045946 · doc4.xml · derivative · entry 5 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Class A Common Stock · 12,000 shares Expires 2021-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on February 11, 2011 and are fully vested. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:30 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 3,000 | $57.90 | $173,700.00 |
DisclosureSEC source: 0001209191-20-045946 · doc4.xml · nonDerivative · entry 4 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:30 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 3,000 | $55.92 | $167,760.00 |
DisclosureSEC source: 0001209191-20-045946 · doc4.xml · nonDerivative · entry 3 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.90 to $55.98, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:30 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 6,000 | $54.78 | $328,680.00 |
DisclosureSEC source: 0001209191-20-045946 · doc4.xml · nonDerivative · entry 2 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:30 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 12,000 | $11.28 | $135,360.00 |
DisclosureSEC source: 0001209191-20-045946 · doc4.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 20:33 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 9,076 | $0.00 Strike: $11.28 | $0.00 |
DisclosureSEC source: 0001209191-20-036621 · doc4.xml · derivative · entry 3 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Class A Common Stock · 9,076 shares Expires 2021-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on February 11, 2011 and are fully vested. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 20:33 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 9,076 | $51.00 | $462,876.00 |
DisclosureSEC source: 0001209191-20-036621 · doc4.xml · nonDerivative · entry 2 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 20:33 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 9,076 | $11.28 | $102,377.28 |
DisclosureSEC source: 0001209191-20-036621 · doc4.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:40 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 40,000 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001209191-20-004849 · doc4.xml · derivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, GC, Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2030-01-22 F1 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 21:38 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 3,076 | $0.00 Strike: $11.86 | $0.00 |
DisclosureSEC source: 0001209191-19-061307 · doc4.xml · derivative · entry 3 Huller Kelly · CIK 0001768417 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,076 shares Expires 2020-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on June 16, 2010 and are fully vested. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 21:38 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 6,460 | $58.90 | $380,494.00 |
DisclosureSEC source: 0001209191-19-061307 · doc4.xml · nonDerivative · entry 2 Huller Kelly · CIK 0001768417 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.